Unichem Laboratories Ltd (UNICHEMLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 270205,
    "name": "Unichem Labs.",
    "stock_name": "Unichem Labs.",
    "full_name": "Unichem Laboratories Ltd",
    "name_url": "stocks-analysis/unichem-labs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "455.80",
    "chg": -9.25,
    "chgp": "-1.99%",
    "dir": -1,
    "prev_price": "465.05",
    "mcapval": "3,236.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506690,
    "symbol": "UNICHEMLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE351A01035",
    "curr_date": "Dec 12",
    "curr_time": "",
    "bse_nse_vol": "3.74 k",
    "exc_status": "Active",
    "traded_date": "Dec 12, 2025",
    "traded_date_str": "2025 12 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/unichem-labs-270205-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Unichem Laboratories Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unichem-laboratories-technical-momentum-shifts-amid-mixed-indicator-signals-3757005",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/UnichemLaborato_technicaldot_3757005.png",
        "date": "2025-12-12 08:02:34",
        "description": "Unichem Laboratories has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. The stock’s recent price movements and technical indicators suggest a nuanced market assessment amid broader sector and benchmark comparisons."
      },
      {
        "title": "Unichem Laboratories Technical Momentum Shifts Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unichem-laboratories-faces-bearish-momentum-amid-technical-downgrade-3755878",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/UnichemLaborato_technicaldot_3755878.png",
        "date": "2025-12-11 08:02:05",
        "description": "Unichem Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting notable shifts in its technical momentum as recent evaluation adjustments reflect a more cautious market stance. The stock’s price action and technical indicators reveal a complex interplay of bearish and mildly bullish signals, underscoring the challenges faced amid broader market dynamics."
      },
      {
        "title": "Unichem Laboratories Stock Falls to 52-Week Low of Rs.434",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unichem-laboratories-stock-falls-to-52-week-low-of-rs434-amidst-continued-downtrend-3753437",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/UnichemLaborato_priceRelatedfactors_3753437.png",
        "date": "2025-12-09 09:56:13",
        "description": "Unichem Laboratories has reached a new 52-week low, with its share price touching Rs.434 today. This marks a significant decline amid a broader market environment where the Sensex has also experienced downward pressure, though the pharmaceutical company’s stock has notably underperformed its sector and benchmark indices over the past year."
      },
      {
        "title": "Unichem Laboratories Stock Falls to 52-Week Low Amidst Market Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unichem-laboratories-stock-falls-to-52-week-low-amidst-continued-downtrend-3751817",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/UnichemLaborato_priceRelatedfactors_3751817.png",
        "date": "2025-12-08 16:02:10",
        "description": "Unichem Laboratories has reached a new 52-week low, closing near Rs 438.5, marking a significant price level for the pharmaceutical company as it navigates a challenging market environment and subdued financial performance."
      },
      {
        "title": "Unichem Labs. Sees Revision in Market Evaluation Amidst Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/unichem-labs-downgraded-to-sell-by-marketsmojo-amid-weak-financial-and-technical-signals-3735304",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/UnichemLabs_mojoScore_3735304.png",
        "date": "2025-11-28 10:04:56",
        "description": "Unichem Labs., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment follows a period marked by subdued financial performance and cautious market sentiment, underscoring the complexities faced by the company in the current environment."
      },
      {
        "title": "Is Unichem Labs. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-unichem-labs-technically-bullish-or-bearish-3696235",
        "imagepath": "",
        "date": "2025-11-13 08:13:03",
        "description": "As of 12 November 2025, the technical trend for Unichem Labs has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include the daily moving averages indicating bearish momentum, and the weekly KST and Dow Theory both showing bearish signals. The MACD on a monthly basis is mildly bearish, while the Bollinger Bands also reflect a mildly bearish outlook. Despite some mildly bullish signals from the weekly MACD and OBV, the overall technical picture remains negative, particularly given the significant year-to-date decline of 35.14% compared to the Sensex's 8.10% gain...."
      },
      {
        "title": "Is Unichem Labs. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-unichem-labs-overvalued-or-undervalued-3696014",
        "imagepath": "",
        "date": "2025-11-13 08:08:16",
        "description": "As of 12 November 2025, the valuation grade for Unichem Labs. has moved from very attractive to attractive, indicating a shift in perception regarding its value. The company is currently assessed as undervalued, particularly in comparison to its peers. Key ratios include a PE ratio of 22.88, an EV to EBITDA of 14.21, and a PEG ratio of 0.05, which suggests strong growth potential relative to its price.\n\nIn the peer comparison, Unichem Labs. stands out against companies like Sun Pharma, which has a PE ratio of 35.94, and Cipla, with a PE ratio of 22.56. This positions Unichem Labs. favorably within the industry, especially considering its attractive valuation amidst peers that are deemed expensive. Despite recent stock performance lagging behind the Sensex over the past year, the long-term outlook remains positive, with a notable 5-year return of 105.39% compared to the Sensex's 94.82%...."
      },
      {
        "title": "Unichem Laboratories Faces Mixed Technical Trends Amid Market Challenges and Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unichem-laboratories-technical-trend-shifts-from-mildly-bearish-to-bearish-amid-stock-decline-3696446",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/UnichemLaborato_technicaldot_3696446.png",
        "date": "2025-11-13 08:02:17",
        "description": "Unichem Laboratories, a small-cap pharmaceutical company, has faced significant challenges over the past year, with a notable decline in stock performance compared to the broader market. Despite recent technical indicators suggesting bearish sentiment, the company has shown resilience with strong long-term returns, indicating potential for strategic improvements."
      },
      {
        "title": "How has been the historical performance of Unichem Labs.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-unichem-labs-3694589",
        "imagepath": "",
        "date": "2025-11-12 23:47:31",
        "description": "Answer:\nThe historical performance of Unichem Labs shows a significant recovery and growth in recent years, particularly in the fiscal year ending March 2025.\n\nBreakdown:\nUnichem Labs has experienced a steady increase in net sales, rising from 1,125.01 crore in March 2020 to 2,110.97 crore in March 2025. This growth is reflected in total operating income, which also increased from 1,125.01 crore to 2,110.97 crore over the same period. The company's total expenditure, excluding depreciation, rose from 1,263.54 crore in March 2019 to 1,846.11 crore in March 2025, yet the operating profit (PBDIT) improved significantly, reaching 300.18 crore in March 2025, compared to a loss of 7.04 crore in March 2023. Profit before tax turned positive at 154.59 crore in March 2025, recovering from a loss of 176.36 crore in March 2023, while profit after tax also saw a turnaround, achieving 137.52 crore in March 2025 after lo..."
      }
    ],
    "total": 529,
    "sid": "270205",
    "stock_news_url": "https://www.marketsmojo.com/news/unichem-laboratories-270205"
  },
  "announcements": [
    {
      "details": "Unichem Laboratories Limited has informed the Exchange regarding 'ANDA approval for Unichem's Buspirone Hydrochloride '.",
      "source": "NSE",
      "caption": "Unichem Laboratories Limited - Updates",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Unichem Laboratories Limited has informed the Exchange regarding Disclosure on Related Party transactions for half year ended September 30, 2019.",
      "source": "NSE",
      "caption": "Unichem Laboratories Limited - Other General Purpose",
      "datetime": "15-Nov-2019"
    },
    {
      "details": " <table><tr><td>Unichem Laboratories Limited has informed the Exchange regarding 'USFDA approval for the Company's plant at Kolhapur'. </td></tr></table>",
      "source": "NSE",
      "caption": "Updates",
      "datetime": "20-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Unichem Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 01 Aug 22",
          "dt": "2022-08-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Unichem Laboratories Ltd has announced <strong>2:5</strong> stock split, ex-date: 21 Oct 10",
          "dt": "2010-10-21",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Unichem Laboratories Technical Momentum Shifts Amid Mixed Market Signals

2025-12-12 08:02:34

Unichem Laboratories has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. The stock’s recent price movements and technical indicators suggest a nuanced market assessment amid broader sector and benchmark comparisons.

Unichem Laboratories Technical Momentum Shifts Amid Market Challenges

2025-12-11 08:02:05

Unichem Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting notable shifts in its technical momentum as recent evaluation adjustments reflect a more cautious market stance. The stock’s price action and technical indicators reveal a complex interplay of bearish and mildly bullish signals, underscoring the challenges faced amid broader market dynamics.

Unichem Laboratories Stock Falls to 52-Week Low of Rs.434

2025-12-09 09:56:13

Unichem Laboratories has reached a new 52-week low, with its share price touching Rs.434 today. This marks a significant decline amid a broader market environment where the Sensex has also experienced downward pressure, though the pharmaceutical company’s stock has notably underperformed its sector and benchmark indices over the past year.

Unichem Laboratories Stock Falls to 52-Week Low Amidst Market Pressures

2025-12-08 16:02:10

Unichem Laboratories has reached a new 52-week low, closing near Rs 438.5, marking a significant price level for the pharmaceutical company as it navigates a challenging market environment and subdued financial performance.

Unichem Labs. Sees Revision in Market Evaluation Amidst Challenging Financial Trends

2025-11-28 10:04:56

Unichem Labs., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment follows a period marked by subdued financial performance and cautious market sentiment, underscoring the complexities faced by the company in the current environment.

Is Unichem Labs. technically bullish or bearish?

2025-11-13 08:13:03

As of 12 November 2025, the technical trend for Unichem Labs has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include the daily moving averages indicating bearish momentum, and the weekly KST and Dow Theory both showing bearish signals. The MACD on a monthly basis is mildly bearish, while the Bollinger Bands also reflect a mildly bearish outlook. Despite some mildly bullish signals from the weekly MACD and OBV, the overall technical picture remains negative, particularly given the significant year-to-date decline of 35.14% compared to the Sensex's 8.10% gain....

Is Unichem Labs. overvalued or undervalued?

2025-11-13 08:08:16

As of 12 November 2025, the valuation grade for Unichem Labs. has moved from very attractive to attractive, indicating a shift in perception regarding its value. The company is currently assessed as undervalued, particularly in comparison to its peers. Key ratios include a PE ratio of 22.88, an EV to EBITDA of 14.21, and a PEG ratio of 0.05, which suggests strong growth potential relative to its price. In the peer comparison, Unichem Labs. stands out against companies like Sun Pharma, which has a PE ratio of 35.94, and Cipla, with a PE ratio of 22.56. This positions Unichem Labs. favorably within the industry, especially considering its attractive valuation amidst peers that are deemed expensive. Despite recent stock performance lagging behind the Sensex over the past year, the long-term outlook remains positive, with a notable 5-year return of 105.39% compared to the Sensex's 94.82%....

Unichem Laboratories Faces Mixed Technical Trends Amid Market Challenges and Resilience

2025-11-13 08:02:17

Unichem Laboratories, a small-cap pharmaceutical company, has faced significant challenges over the past year, with a notable decline in stock performance compared to the broader market. Despite recent technical indicators suggesting bearish sentiment, the company has shown resilience with strong long-term returns, indicating potential for strategic improvements.

How has been the historical performance of Unichem Labs.?

2025-11-12 23:47:31

Answer: The historical performance of Unichem Labs shows a significant recovery and growth in recent years, particularly in the fiscal year ending March 2025. Breakdown: Unichem Labs has experienced a steady increase in net sales, rising from 1,125.01 crore in March 2020 to 2,110.97 crore in March 2025. This growth is reflected in total operating income, which also increased from 1,125.01 crore to 2,110.97 crore over the same period. The company's total expenditure, excluding depreciation, rose from 1,263.54 crore in March 2019 to 1,846.11 crore in March 2025, yet the operating profit (PBDIT) improved significantly, reaching 300.18 crore in March 2025, compared to a loss of 7.04 crore in March 2023. Profit before tax turned positive at 154.59 crore in March 2025, recovering from a loss of 176.36 crore in March 2023, while profit after tax also saw a turnaround, achieving 137.52 crore in March 2025 after lo...

View All News